Back

Subcutaneous P2Y12 inhibition

30 August 2024 (13:45 - 14:00)
Organised by: Logo
Congress Presentation Part of: Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon? Antiplatelet Drugs ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Robert Storey

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Subcutaneous GP IIb/IIIa inhibition
Professor J. ten Berg (Nieuwegein, NL)
Slides Video
Presentation thumbnail
Glycoprotein VI inhibition
Professor C. Christersson (Uppsala, SE)
Slides Video
Presentation thumbnail
FXIa inhibition
Professor D. Gorog (London, GB)
Slides Video
Presentation thumbnail
Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon? - discussion
Video

Access the full session

Session thumbnail
Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 13:45 CET
You may be interested in
thumbnail
Congress Presentation
Injectable and intravenous P2Y12 inhibitors in patients with acute myocardial infarction.
26 August 2022
thumbnail
Congress Presentation
In vitro comparison of platelet aggregation between zalunfiban and selatogrel in healthy donors
28 August 2023
thumbnail
Congress Presentation
Phase I results of both IV and oral administration for CG-0255: a novel fast-acting antiplatelet drug with a new activation pathway
31 August 2024
thumbnail
Congress Presentation
Panel discussion - PANTHER.
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources